Literature DB >> 3292425

Orthotopic liver transplantation for fulminant and subacute hepatic failure.

A C Stieber1, G Ambrosino, D Van Thiel, S Iwatsuki, T E Starzl.   

Abstract

The fulminant hepatic failure (FHF) is a condition characterized by massive hepatocyte necrosis and one that is associated with severe liver and/or other organ-systems insufficiency leading to death in up to 85 per cent of the cases with medical treatment only. Although various expedients have been tried in order to save these patients, the necrosis is usually so massive that it is beyond regeneration. At present, the only hope lies with orthotopic liver transplantation (OLTx), which has become progressively more successful during the last few years. Various considerations pertaining to OLTx are discussed, as well as our series of 40 patients who were transplanted for FHF, with a survival of 57 per cent.

Entities:  

Mesh:

Year:  1988        PMID: 3292425      PMCID: PMC2965556     

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  6 in total

1.  Liver transplantation in the ciclosporin era.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel
Journal:  Prog Allergy       Date:  1986

2.  Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL).

Authors: 
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

3.  Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation.

Authors:  J Rakela; S B Kurtz; J T McCarthy; J Ludwig; N L Ascher; J R Bloomer; P L Claus
Journal:  Gastroenterology       Date:  1986-06       Impact factor: 22.682

4.  Orthotopic liver transplantation for acute fulminant Wilson disease.

Authors:  R J Sokol; P D Francis; S H Gold; D M Ford; G M Lum; D R Ambruso
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

5.  Liver transplantation for fulminant hepatic failure.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; B W Shaw; T E Starzl; R R Shade; D H Van Thiel
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

6.  Earlier charcoal haemoperfusion in fulminant hepatic failure.

Authors:  A E Gimson; S Braude; P J Mellon; J Canalese; R Williams
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

  6 in total
  5 in total

Review 1.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 2.  Fulminant hepatitis.

Authors:  S Sinclair; A Wakefield; G Levy
Journal:  Springer Semin Immunopathol       Date:  1990

3.  [Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center].

Authors:  J Lerut; A C Stieber; L Makowka; C O Esquivel; S Iwatsuki; R D Gordon; T E Starzl
Journal:  Helv Chir Acta       Date:  1989-08

4.  Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.

Authors:  S B Sinclair; G A Levy
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

5.  Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Authors:  S B Sinclair; P D Greig; L M Blendis; M Abecassis; E A Roberts; M J Phillips; R Cameron; G A Levy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.